Aurinia Pharmaceuticals Inc (NASDAQ:AUPH – Free Report) (TSE:AUP) – Leerink Partnrs upped their Q1 2026 earnings per share (EPS) estimates for shares of Aurinia Pharmaceuticals in a research report issued to clients and investors on Tuesday, November 4th. Leerink Partnrs analyst J. Schwartz now anticipates that the biotechnology company will post earnings of $0.18 per [...]
Leerink Partnrs Issues Positive Outlook for AUPH Earnings
